This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Telix Pharmaceuticals Class Action Lawsuit
Business class action lawsuit

Telix Pharmaceuticals Class Action Lawsuit

Analysis based on 39 articles · First reported Nov 13, 2025 · Last updated Dec 31, 2025

Sentiment
-50
Attention
4
Articles
39
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Telix Pharmaceuticals for alleged false statements regarding its prostate cancer therapeutic candidates and supply chain is expected to negatively impact its stock price and investor confidence. The involvement of multiple law firms like Rosen Law Firm, The Gross Law Firm, and Levi & Korsinsky indicates a significant legal challenge for Telix Pharmaceuticals.

Pharmaceuticals Legal Services
Event Summary

Telix Pharmaceuticals is facing a class action securities lawsuit filed by multiple law firms, including Rosen Law Firm, The Gross Law Firm, and Levi & Korsinsky. The lawsuit alleges that Telix Pharmaceuticals made materially false and misleading statements between February 21, 2025, and August 28, 2025, concerning the progress of its prostate cancer therapeutic candidates and the quality of its supply chain and partners. Investors who purchased shares during this period are encouraged to join the lawsuit, with a lead plaintiff deadline set for January 9, 2026. The legal actions by these firms aim to recover losses for affected shareholders.

Entities Involved
stock
Telix Pharmaceuticals
Telix Pharmaceuticals is the defendant in a class action lawsuit alleging that it made materially false and misleading statements regarding its prostate cancer therapeutic candidates and supply chain. This event negatively impacts its stock price and reputation.
Importance 100.0 Sentiment -70.0
per
Joseph E. Levi
Joseph E. Levi, an attorney at Levi & Korsinsky, is a contact for investors regarding the Telix Pharmaceuticals class action lawsuit.
Importance 30.0 Sentiment 20.0
priv
Levi & Korsinsky
Importance 0.0 Sentiment 0.0
priv
Rosen Law Firm
Importance 0.0 Sentiment 0.0
per
Philip Kim
Importance 0.0 Sentiment 0.0
per
Lawrence Rosen
Importance 0.0 Sentiment 0.0
Relationships
Joseph E. Levi partner ↔ Levi & Korsinsky Joseph E. Levi is an attorney and named partner at Levi & Korsinsky, where he represents investors in securities class a
Joseph E. Levi related ↔ Rosen Law Firm
Joseph E. Levi related ↔ Philip Kim
Joseph E. Levi related ↔ Lawrence Rosen
Levi & Korsinsky related ↔ Rosen Law Firm
Levi & Korsinsky related ↔ Philip Kim
Levi & Korsinsky related ↔ Lawrence Rosen
Rosen Law Firm related ↔ Philip Kim
Rosen Law Firm related ↔ Lawrence Rosen
Philip Kim attorney ↔ Lawrence Rosen Philip Kim is an attorney at the Rosen Law Firm, working under the direction of founding partner Lawrence Rosen. Kim fre
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.